Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
TRACON Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TCON
Nasdaq
8731
https://www.traconpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for TRACON Pharmaceuticals Inc
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 3:03 pm
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
- Mar 5th, 2024 9:02 pm
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
- Feb 28th, 2024 9:02 pm
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
- Dec 20th, 2023 1:00 pm
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
- Nov 21st, 2023 12:32 pm
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
- Nov 20th, 2023 1:00 pm
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Q3 2023 Earnings Call Transcript
- Nov 12th, 2023 1:47 pm
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 9th, 2023 9:02 pm
TRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023
- Oct 31st, 2023 8:02 pm
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
- Sep 18th, 2023 12:00 pm
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences
- Sep 5th, 2023 8:02 pm
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
- Aug 25th, 2023 11:20 am
Q2 2023 TRACON Pharmaceuticals Inc Earnings Call
- Aug 15th, 2023 12:43 pm
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
- Aug 14th, 2023 8:02 pm
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023
- Aug 2nd, 2023 8:05 pm
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
- Jul 11th, 2023 12:00 pm
TRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial
- Jun 20th, 2023 12:00 pm
TRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference
- Jun 16th, 2023 12:00 pm
TRACON Pharmaceuticals Announces Enforcement Action to Collect Binding Arbitration Award from I-Mab Biopharma
- Jun 15th, 2023 12:00 pm
TRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference
- Jun 2nd, 2023 12:00 pm
Scroll